Last updated on February 2019

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma


Brief description of study

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Detailed Study Description

The purpose of the study is to assess the efficacy, safety, and tolerability when combining pembrolizumab with epacadostat or placebo in subjects with unresectable or metastatic melanoma.

Clinical Study Identifier: TX145132

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.